Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Beyond malignancy: the role of carbohydrate antigen 125 in heart failure.

Hung CL, Hung TC, Lai YH, Lu CS, Wu YJ, Yeh HI.

Biomark Res. 2013 Aug 30;1(1):25. doi: 10.1186/2050-7771-1-25.

2.

Tumour biomarkers in heart failure: is there a role for CA-125?

Yilmaz MB, Nikolaou M, Cohen Solal A.

Eur J Heart Fail. 2011 Jun;13(6):579-83. doi: 10.1093/eurjhf/hfr022. Epub 2011 Apr 26. Review.

3.

A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.

McKenna C, Burch J, Suekarran S, Walker S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Lorgelly P, Fenwick L, Palmer S.

Health Technol Assess. 2010 May;14(24):1-162. doi: 10.3310/hta14240. Review.

4.

Carbohydrate antigen 125: a new biomarker in heart failure.

Vizzardi E, D'Aloia A, Curnis A, Dei Cas L.

Cardiol Rev. 2013 Jan-Feb;21(1):23-6. doi: 10.1097/CRD.0b013e318265f58f. Review.

PMID:
22735832
5.

Comprehensive review of the prognostic value of galectin-3 in heart failure.

Coburn E, Frishman W.

Cardiol Rev. 2014 Jul-Aug;22(4):171-5. doi: 10.1097/CRD.0000000000000013. Review.

PMID:
24407048
6.

New mechanism of elevated CA125 in heart failure: the mechanical stress and inflammatory stimuli initiate CA125 synthesis.

Huang F, Chen J, Liu Y, Zhang K, Wang J, Huang H.

Med Hypotheses. 2012 Sep;79(3):381-3. doi: 10.1016/j.mehy.2012.05.042. Epub 2012 Jun 27.

PMID:
22743023
7.

Long-term prognostic value of CA 125 serum levels in mild to moderate heart failure patients.

Vizzardi E, D'Aloia A, Pezzali N, Bugatti S, Curnis A, Dei Cas L.

J Card Fail. 2012 Jan;18(1):68-73. doi: 10.1016/j.cardfail.2011.09.012. Epub 2011 Nov 9.

PMID:
22196844
8.

Clinical utility of antigen carbohydrate 125 in heart failure.

Núñez J, Miñana G, Núñez E, Chorro FJ, Bodí V, Sanchis J.

Heart Fail Rev. 2014 Sep;19(5):575-84. doi: 10.1007/s10741-013-9402-y. Review.

PMID:
23925386
9.

Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCE-HF). Study design.

Núñez J, Merlos P, Fácila L, Llàcer P, Bosch MJ, Bertomeu-Martínez V, García-Blas S, Montagud V, Pedrosa V, Mendizábal A, Cordero A, Miñana G, Sanchis J, Bertomeu-González V; CHANCE-HF Investigators.

Rev Esp Cardiol (Engl Ed). 2015 Feb;68(2):121-8. doi: 10.1016/j.rec.2014.03.018. Epub 2014 Aug 10.

PMID:
25623430
10.

Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(13):1-60. Epub 2005 Sep 1.

11.

Insights into the clinical implications of carbohydrate antigen 125 as a biomarker of heart failure: a meta-analysis and systematic review of published studies.

Zhuang J, Faggiano P, Li Q, Pradelli D, Med V, Peng W, Zuo M, Xu Y.

J Cardiovasc Med (Hagerstown). 2014 Dec;15(12):864-72. doi: 10.2459/JCM.0000000000000051. Review.

PMID:
25353973
12.

Fluctuations of tumor markers in heart failure patients pre and post heart transplantation.

Nägele H, Bahlo M, Klapdor R, Rödiger W.

Anticancer Res. 1999 Jul-Aug;19(4A):2531-4.

PMID:
10470189
13.

Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(5):1-70. Epub 2006 Mar 1.

14.

Relation of carbohydrate antigen-125 to left atrial remodeling and its prognostic usefulness in patients with heart failure and preserved left ventricular ejection fraction in women.

Hung CL, Hung TC, Liu CC, Wu YJ, Kuo JY, Hou CJ, Yeh HI.

Am J Cardiol. 2012 Oct 1;110(7):993-1000. doi: 10.1016/j.amjcard.2012.05.030. Epub 2012 Jun 22.

PMID:
22728006
15.

The CA 125 tumour-associated antigen: a review of the literature.

Jacobs I, Bast RC Jr.

Hum Reprod. 1989 Jan;4(1):1-12. Review.

PMID:
2651469
16.

Combined Free Light Chains Are Novel Predictors of Prognosis in Heart Failure.

Jackson CE, Haig C, Welsh P, Dalzell JR, Tsorlalis IK, McConnachie A, Preiss D, McInnes IB, Sattar N, Petrie MC, Gardner RS, McMurray JJ.

JACC Heart Fail. 2015 Aug;3(8):618-25. doi: 10.1016/j.jchf.2015.03.014.

PMID:
26251088
18.

Serum level of tumor marker carbohydrate antigen-CA125 in heart failure.

Durak-Nalbantic A, Resic N, Kulic M, Pecar E, Zvizdic F, Dzubur A, Dilic M, Gojak R, Sokolovic S, Hodzic E, Brdjanovic S.

Med Arch. 2013;67(4):241-4.

PMID:
24520743
20.

Community-based care for the specialized management of heart failure: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(17):1-42. Epub 2009 Nov 1.

Supplemental Content

Support Center